Developing Transformative Therapies for Patients with Cancer
Maximizing for clinical and commercial success
- Validated, de-risked oncology targets
- Highly differentiated best-in-class assets with potential to maximize patient benefit
- Areas of high unmet need, significant market opportunity
A company dedicated to breakthrough research
We are a clinical-stage, oncology focused biotechnology company committed to delivering best in-class targeted therapies that improve outcomes and transform the lives of patients with cancer.
